The effect of a single inhaled dose of a VLA-4 antagonist on allergen-induced airway responses and airway inflammation in patients with asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 61, Issue 9, 2006, Pages 1097-1103

  Ravensberg, A J ^a   Luijk, B ^b   Westers, P ^c   Hiemstra, P S ^a   Sterk, P J ^a   Lammers, J W ^b   Rabe, K F ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Airway inflammation; Anti inflammatory agent; Asthma; Bronchial allergen challenge; Very late antigen 4

Indexed keywords

ALLERGEN; ANTIINFLAMMATORY AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FLUTICASONE PROPIONATE; GW 559090X; GW 599090X; HOUSE DUST ALLERGEN; METHACHOLINE; NITRIC OXIDE; PLACEBO; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 4; VERY LATE ACTIVATION ANTIGEN 4 ANTAGONIST;

ADULT; ANTIINFLAMMATORY ACTIVITY; AREA UNDER THE CURVE; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG SAFETY; DYSPNEA; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; MALE; MULTICENTER STUDY; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFLAMMATION;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; ALLERGENS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTHMA; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DOUBLE-BLIND METHOD; HUMANS; INFLAMMATION; INTEGRIN ALPHA4BETA1; LUNG; MALE; MIDDLE AGED;

EID: 33746861050     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2006.01146.x     Document Type: Article

References (40)

1. GINA Workshop Report, Global Strategy for Asthma Management and Prevention - updated April 2002 (Scientific information and recommendations for asthma programs. NIH Publication No. 02-3659), 2002.
2. Pearce N, Pekkanen J, Beasley R. How much asthma is really attributable to atopy? Thorax 1999;54:268-272.
3. O'Byrne PM, Dolovich J, Hargreave FE. Late asthmatic responses. Am Rev Respir Dis 1987;136:740-751.
4. Robertson DG, Kerigan AT, Hargreave FE, Chalmers R, Dolovich J. Late asthmatic responses induced by ragweed pollen allergen. J Allergy Clin Immunol 1974;54:244-254.
5. Cartier A, Thomson NC, Frith PA, Roberts R, Hargreave FE. Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber. J Allergy Clin Immunol 1982;70:170-177.
6. Bentley AM, Meng Q, Robinson DS, Hamid Q, Kay AB, Durham SR. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol 1993;8:35-42.
7. Braunstahl GJ, Overbeek SE, Kleinjan A, Prins JB, Hoogsteden HC, Fokkens WJ. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001;107:469-476.
8. Matsui T, Asakura K, Shirasaki H, Kataura A, Himi T. Relationship between infiltrating cells and adhesion molecules in the nasal mucosa of patients with allergic rhinitis. Acta Otolaryngol 2000;120:973-980.
9. Pretolani M, Ruffie C, Silva JR, Joseph D, Lobb RR, Vargaftig BB. Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways. J Exp Med 1994;180:795-805.
10. Henderson WR Jr, Chi EY, Albert RK, Chu SJ, Lamm WJ, Rochon Y et al. Blockade of CD49d (alpha4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. J Clin Invest 1997;100:3083-3092.
11. Borchers MT, Crosby J, Farmer S, Sypek J, Ansay T, Lee NA et al. Blockade of CD49d inhibits allergic airway pathologies independent of effects on leukocyte recruitment. Am J Physiol Lung Cell Mol Physiol 2001;280:L813-L821.
12. Parameswaran K, Inman MD, Watson RM, Morris MM, Efthimiadis A, Ventresca PG et al. Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers. Can Respir J 2000;7:313-319.
13. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:5-40.
14. Sterk PJ, Fabbri LM, Quanjer PH, Cockcroft DW, O'Byrne PM, Anderson SD et al. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:53-83.
15. Cockcroft DW, Murdock KY, Kirby J, Hargreave F. Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. Am Rev Respir Dis 1987;135:264-267.
16. Diamant Z, Timmers MC, van der Veen H, Friedman BS, De Smet M, Depre M et al. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo. J Allergy Clin Immunol 1995;95(1 Pt 1):42-51.
17. ATS/ERS. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005;171:912-930.
18. Diamant Z, Grootendorst DC, Veselic-Charvat M, Timmers MC, De Smet M, Leff JA et al. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma. Clin Exp Allergy 1999;29:42-51.
19. Milne AA, Piper PJ. Role of the VLA-4 integrin in leucocyte recruitment and bronchial hyperresponsiveness in the guinea-pig. Eur J Pharmacol 1995;282:243-249.
20. Laberge S, Rabb H, Issekutz TB, Martin JG. Role of VLA-4 and LFA-1 in allergen-induced airway hyperresponsiveness and lung inflammation in the rat. Am J Respir Crit Care Med 1995;151(3 Pt 1):822-829.
21. Rabb HA, Olivenstein R, Issekutz TB, Renzi PM, Martin JG. The role of the leukocyte adhesion molecules VLA-4, LFA-1, and Mac-1 in allergic airway responses in the rat. Am J Respir Crit Care Med 1994;149:1186-1191.
22. Diamant Z, Kuperus J, Baan R, Nietzmann K, Millet S, Mendes P et al. Effect of a very late antigen-4 receptor antagonist on allergen-induced airway responses and inflammation in asthma. Clin Exp Allergy 2005;35:1080-1087.
23. Norris V, Choong L, Tran D, Corden Z, Boyce M, Arshad H et al. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma. J Allergy Clin Immunol 2005;116:761-767.
24. Wong BJ, Dolovich J, Ramsdale EH, O'Byrne P, Gontovnick L, Denburg JA et al. Formoterol compared with beclomethasone and placebo on allergen-induced asthmatic responses. Am Rev Respir Dis 1992;146(5 Pt 1):1156-1160.
25. Kidney JC, Boulet LP, Hargreave FE, Deschesnes F, Swystun VA, O'Byrne PM et al. Evaluation of single-dose inhaled corticosteroid activity with an allergen challenge model. J Allergy Clin Immunol 1997;100:65-70.
26. Durham SR, Craddock CF, Cookson WO, Benson MK. Increases in airway responsiveness to histamine precede allergen-induced late asthmatic responses. J Allergy Clin Immunol 1988;82(5 Pt 1):764-770.
27. Rossi GA, Crimi E, Lantero S, Gianiorio P, Oddera S, Crimi P et al. Late-phase asthmatic reaction to inhaled allergen is associated with early recruitment of eosinophils in the airways. Am Rev Respir Dis 1991;144:379-383.
28. Gauvreau GM, Doctor J, Watson RM, Jordana M, O'Byrne PM. Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med 1996;154:1267-1271.
29. Subbarao P, Dorman SC, Rerecich T, Watson RM, Gauvreau GM, O'Byrne PM. Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy. J Allergy Clin Immunol 2005;115:745-750.
30. Kharitonov SA, O'Connor BJ, Evans DJ, Barnes PJ. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med 1995;151:1894-1899.
31. Taylor DA, McGrath JL, Orr LM, Barnes PJ, O'Connor BJ. Effect of endogenous nitric oxide inhibition on airway responsiveness to histamine and adenosine-5′-monophosphate in asthma. Thorax 1998;53:483-489.
32. Tsai YG, Lee MY, Yang KD, Chu DM, Yuh YS, Hung CH. A single dose of nebulized budesonide decreases exhaled nitric oxide in children with acute asthma. J Pediatr 2001;139:433-437.
33. Luijk B, Kempsford RD, Wright AM, Zanen P, Lammers JW. Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction. Eur Respir J 2004;23:559-564.
34. Metzger WJ, Zavala D, Richerson HB, Moseley P, Iwamota P, Monick M et al. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Description of the model and local airway inflammation. Am Rev Respir Dis 1987;135:433-440.
35. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-314.
36. Dang B, Wiehler S, Patel KD. Increased PSGL-1 expression on granulocytes from allergic-asthmatic subjects results in enhanced leukocyte recruitment under flow conditions. J Leukoc Biol 2002;72:702-710.
37. Hakansson L, Bjornsson E, Janson C, Schmekel B. Increased adhesion to vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 of eosinophils from patients with asthma. J Allergy Clin Immunol 1995;96(6 Pt 1):941-950.
38. Kaminuma O, Fujimura H, Fushimi K, Nakata A, Sakai A, Chishima S et al. Dynamics of antigen-specific helper T cells at the initiation of airway eosinophilic inflammation. Eur J Immunol 2001;31:2669-2679.
39. Gascoigne MH, Holland K, Page CP, Shock A, Robinson M, Foulkes R et al. The effect of anti-integrin monoclonal antibodies on antigen-induced pulmonary inflammation in allergic rabbits. Pulm Pharmacol Ther 2003;16:279-285.
40. Sedgwick JB, Jansen KJ, Kennedy JD, Kita H, Busse WW. Effects of the very late adhesion molecule 4 antagonist WAY103 on human peripheral blood eosinophil vascular cell adhesion molecule 1-dependent functions. J Allergy Clin Immunol 2005;116:812-819.